XSAT:ISAB (Sweden)
Â
Ordinary Shares
kr
0.22
+0.012 (+5.69%)
Jul 10
Business Description
Inhalation Sciences Sweden AB
ISIN : SE0009983893
Share Class Description:
XSAT:ISAB: Ordinary SharesTotal Employee Number:
6Compare
Compare
Traded in other countries / regions
ISAB.Sweden IPO Date
2017-09-28Description
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 113 | |||||
Equity-to-Asset | 0.72 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.67 | |||||
Beneish M-Score | 1.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -52.1 | |||||
3-Year EBITDA Growth Rate | 26.9 | |||||
3-Year EPS without NRI Growth Rate | 28.5 | |||||
3-Year FCF Growth Rate | 26.8 | |||||
3-Year Book Growth Rate | -32.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.4 | |||||
9-Day RSI | 46.29 | |||||
14-Day RSI | 47.07 | |||||
3-1 Month Momentum % | -14.23 | |||||
6-1 Month Momentum % | -53.73 | |||||
12-1 Month Momentum % | -58.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.39 | |||||
Quick Ratio | 2.55 | |||||
Cash Ratio | 1.09 | |||||
Days Inventory | 475.25 | |||||
Days Sales Outstanding | 47.92 | |||||
Days Payable | 150.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -45.4 | |||||
Shareholder Yield % | -126.02 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.92 | |||||
Operating Margin % | -145.99 | |||||
Net Margin % | -145.94 | |||||
EBITDA Margin % | -139.26 | |||||
FCF Margin % | -181.88 | |||||
OCF Margin % | -181.88 | |||||
ROE % | -106.83 | |||||
ROA % | -84.16 | |||||
ROIC % | -189.49 | |||||
3-Year ROIIC % | -62.54 | |||||
ROC (Joel Greenblatt) % | -486.66 | |||||
ROCE % | -106.77 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.25 | |||||
PB Ratio | 1.21 | |||||
Price-to-Tangible-Book | 1.24 | |||||
EV-to-EBIT | -0.92 | |||||
EV-to-Forward-EBIT | 205.14 | |||||
EV-to-EBITDA | -0.97 | |||||
EV-to-Revenue | 1.35 | |||||
EV-to-Forward-Revenue | 4.42 | |||||
EV-to-FCF | -0.74 | |||||
Price-to-GF-Value | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.31 | |||||
| Price-to-Net-Cash | 22.3 | |||||
Earnings Yield (Greenblatt) % | -108.7 | |||||
FCF Yield % | -101.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inhalation Sciences Sweden AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 6.38 | ||
| EPS (TTM) (kr) | -0.29 | ||
| Beta | -0.1373 | ||
| 3-Year Sharpe Ratio | -1.11 | ||
| 3-Year Sortino Ratio | -1.41 | ||
| Volatility % | 72.46 | ||
| 14-Day RSI | 47.07 | ||
| 14-Day ATR (kr) | 0.029436 | ||
| 20-Day SMA (kr) | 0.2307 | ||
| 12-1 Month Momentum % | -58.22 | ||
| 52-Week Range (kr) | 0.172 - 0.69 | ||
| Shares Outstanding (Mil) | 51.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inhalation Sciences Sweden AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inhalation Sciences Sweden AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-20 | In 130 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 46 days | ||
| General meeting for 2026 | 2026-06-17 13:00 | 0.22 (+11.45%) | ||
| Annual report for 2025 | 2026-05-27 | 0.42 (+39.93%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 0.24 (+0.85%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.26 (+8.26%) | ||
| Third quarter earnings results for 2025 | 2025-11-21 | 0.37 (-3.16%) | ||
| Second quarter earnings results for 2025 | 2025-08-29 | 0.53 (-2.75%) | ||
| General meeting for 2025 | 2025-06-24 13:00 | 0.54 (+19.47%) | ||
| Annual report for 2024 | 2025-05-27 | 0.49 (-3.53%) |
Show
Entries
Inhalation Sciences Sweden AB Frequently Asked Questions
What is Inhalation Sciences Sweden AB(XSAT:ISAB)'s stock price today?
The current price of XSAT:ISAB is kr0.22. The 52 week high of XSAT:ISAB is kr0.69 and 52 week low is kr0.17.
When is next earnings date of Inhalation Sciences Sweden AB(XSAT:ISAB)?
The next earnings date of Inhalation Sciences Sweden AB(XSAT:ISAB) is 2026-08-28 Est..
Does Inhalation Sciences Sweden AB(XSAT:ISAB) pay dividends? If so, how much?
Inhalation Sciences Sweden AB(XSAT:ISAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Inhalation Sciences Sweden AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers